MoneyWorks4Me

Shilpa Medicare launches pediatric dose Paracetamol Oral Thin Film

22 Jun 2021 Evaluate

Shilpa Medicare has launched first time in the world Oral Thin Film formulation, a pediatric dose Paracetamol Oral Thin Film, under the Brand name Molshil. Shilpa received approval for Molshil Oral Thin Films after sufficiently complying bioequivalence requirements. Shilpa's Paracetamol Oral Thin Films are patent protected and are first of this kind in the world.Shilpa has manufacturing facilities for paracetamol at both Hyderabad and Bangalore. The company has launched Paracetamol Oral Thin Films as 60 mg and 120 mg strengths in Orange Flavor.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..